Douglas E. Paull, MD, Glenda M. Updyke, PA-C, Michael A

Slides:

Advertisements

Similar presentations

Photodynamic Laser Therapy for Lesions in the Airway

Advertisements

Elizabeth A. David, MD, David T

Jeffrey L. Port, MD, Robert J. Korst, MD, Paul C. Lee, MD, Amanda L

Lymphovascular Invasion as a Prognostic Indicator in Stage I Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis Nathan M. Mollberg, DO,

Masatsugu Hamaji, MD, Syed Osman Ali, MD, Bryan M. Burt, MD

A Propensity-Matched Analysis of Wedge Resection and Stereotactic Body Radiotherapy for Early Stage Lung Cancer Jeffrey L. Port, MD, Bhupesh Parashar,

Survival After Surgical Resection for Lung Cancer in Patients With Chronic Obstructive Pulmonary Disease Anders Bugge, MD, May Brit Lund, MD, PhD, Cathrine.

Complete Thoracic Mediastinal Lymphadenectomy Leads to a Higher Rate of Pathologically Proven N2 Disease in Patients With Non-Small Cell Lung Cancer

Thomas J. Birdas, MD, Richard P. M

Outcomes of Sublobar Resection Versus Lobectomy for Stage I Non–Small Cell Lung Cancer: A 13-Year Analysis Amgad El-Sherif, MD, William E. Gooding, MS,

Comparison of Thoracoscopic Segmentectomy and Thoracoscopic Lobectomy for Small-Sized Stage IA Lung Cancer Chenxi Zhong, MD, Wentao Fang, MD, Teng Mao,

Chun Chieh Lin, PhD, MBA, Matthew P

Standard Uptake Value Predicts Survival in Non–Small Cell Lung Cancer

Sarcomatoid Carcinoma of the Lung: A Predictor of Poor Prognosis

Elliot Wakeam, MD, MPH, Meredith Giuliani, MBBS, MEd, Natasha B

The Effectiveness of Postoperative Radiotherapy in Patients With Completely Resected Thymoma: A Meta-Analysis Dong Zhou, MD, Xu-Feng Deng, MD, Quan-Xing.

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD

Clinical Prognosis of Superior Versus Basal Segment Stage I Non-Small Cell Lung Cancer Yoshinori Handa, MD, Yasuhiro Tsutani, MD, PhD, Norifumi Tsubokawa,

Salvage Lung Resection After Definitive Radiation (>59 Gy) for Non-Small Cell Lung Cancer: Surgical and Oncologic Outcomes Julie E. Bauman, MD, Michael.

Morbidity, Survival, and Site of Recurrence After Mediastinal Lymph-Node Dissection Versus Systematic Sampling After Complete Resection for Non-Small.

Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J

Osteopontin Combined With CD44v6, a Novel Prognostic Biomarker in Non-Small Cell Lung Cancer Undergoing Curative Resection Bing-sheng Sun, MD, PhD, Yue.

Video-Assisted Thoracic Surgery Lobectomy: Experience With 1,100 Cases

Lobectomy in Octogenarians With Non-Small Cell Lung Cancer: Ramifications of Increasing Life Expectancy and the Benefits of Minimally Invasive Surgery

Induction Chemotherapy is Not Superior to a Surgery-First Strategy for Clinical N1 Non- Small Cell Lung Cancer Paul J. Speicher, MD, Zachary W. Fitch,

Lymph Node Evaluation Achieved by Open Lobectomy Compared With Thoracoscopic Lobectomy for N0 Lung Cancer Robert E. Merritt, MD, Chuong D. Hoang, MD,

Risk Factors for Lymph Node Metastases and Prognosticators of Survival in Patients Undergoing Pulmonary Metastasectomy for Colorectal Cancer Servet Bölükbas,

Osteopontin-Expressing Macrophages in Non-Small Cell Lung Cancer Predict Survival Yue Li, MD, Bing-sheng Sun, MD, PhD, Baoxiang Pei, MD, Chen-guang Li,

Importance of Ground Glass Opacity Component in Clinical Stage IA Radiologic Invasive Lung Cancer Aritoshi Hattori, MD, Takeshi Matsunaga, MD, Kazuya.

Prognostic Predictors in Non-Small Cell Lung Cancer Patients Undergoing Intentional Segmentectomy Terumoto Koike, MD, PhD, Teruaki Koike, MD, PhD, Yasushi.

Michelle C. Ellis, MD, Brian S. Diggs, PhD, John T. Vetto, MD, Paul H

The Efficacy of Restaging Endobronchial Ultrasound in Patients With Non-Small Cell Lung Cancer After Preoperative Therapy Basil S. Nasir, MBBCh, Ayesha.

Resection of Intraabdominal Tumors With Cavoatrial Extension Using Deep Hypothermic Circulatory Arrest Christopher Lau, MD, Padraic O’Malley, MD, Mario.

Lung Cancer Surgery in Patients With Liver Cirrhosis

Conditional Cancer-Specific Versus Cardiovascular-Specific Survival After Lobectomy for Stage I Non-Small Cell Lung Cancer Shawn S. Groth, MD, MS, Natasha.

Asad A. Shah, MD, Mathias Worni, MD, MHS, Christopher R

Thomas J. Birdas, MD, Richard P. M

Prognostic factors in clinical stage I non–small cell lung cancer

Survival After Lobectomy Versus Segmentectomy for Stage I Non-Small Cell Lung Cancer: A Population-Based Analysis Bryan A. Whitson, MD, PhD, Shawn S.

Expression of Nuclear Factor-κB and Its Clinical Significance in Nonsmall-Cell Lung Cancer Zhenfa Zhang, MD, Jianqun Ma, MD, Ni Li, PhD, Nan Sun, MD,

Use of Amiodarone After Major Lung Resection

Abel Gómez-Caro, MD, Pedro Arguis, MD The Annals of Thoracic Surgery

Number of Lymph Nodes Associated With Maximal Reduction of Long-Term Mortality Risk in Pathologic Node-Negative Non–Small Cell Lung Cancer Raymond U.

Recurrence and Survival After Segmentectomy in Patients With Prior Lung Resection for Early-Stage Non-Small Cell Lung Cancer Lisa M. Brown, MD, Brian.

Andrew P. Dhanasopon, MD, Michelle C. Salazar, MD, Jessica R

Differences in Patterns of Recurrence in Early-Stage Versus Locally Advanced Non- Small Cell Lung Cancer Feiran Lou, MD, MS, Camelia S. Sima, MD, MS,

Results of Superior Vena Cava Reconstruction With Externally Stented- Polytetrafluoroethylene Vascular Prostheses Ikenna C. Okereke, MD, Kenneth A. Kesler,

Radiofrequency Ablation for the Treatment of Pulmonary Metastases

Selective Mediastinal Lymphadenectomy for Clinico-Surgical Stage I Non–Small Cell Lung Cancer Morihito Okada, MD, PhD, Toshihiko Sakamoto, MD, PhD, Tsuyoshi.

Impact of Pulmonary Function Measurements on Long-Term Survival After Lobectomy for Stage I Non-Small Cell Lung Cancer Mark F. Berry, MD, Chi-Fu Jeffrey.

Lymph Node Assessment and Impact on Survival in Video-Assisted Thoracoscopic Lobectomy or Segmentectomy Haiyu Zhou, MD, Luis F. Tapias, MD, Henning A.

Radiofrequency Ablation for Stage I Non-Small Cell Lung Cancer: Management of Locoregional Recurrence Michael Lanuti, MD, Amita Sharma, MD, Henning Willers,

Number of Metastatic Lymph Nodes in Resected Non–Small Cell Lung Cancer Predicts Patient Survival Jin Gu Lee, MD, Chang Young Lee, MD, In Kyu Park, MD,

Arman Kilic, BS, Matthew J. Schuchert, MD, Brian L

Margin Distance Does Not Influence Recurrence and Survival After Wedge Resection for Lung Cancer Giulio Maurizi, MD, Antonio D’Andrilli, MD, Anna Maria.

Shared Decision Making and Effective Risk Communication in the High-Risk Patient With Operable Stage I Non-Small Cell Lung Cancer Pamela Samson, MD,

Neal S Goldstein, MD The Annals of Thoracic Surgery

Pneumonectomy After Chemoradiation Therapy for Non-Small Cell Lung Cancer: Does “Side” Really Matter? Anthony W. Kim, MD, L. Penfield Faber, MD, William.

Effect of Formalin Fixation on Tumor Size Determination in Stage I Non-Small Cell Lung Cancer Po-Kuei Hsu, MD, Hsu-Chih Huang, MD, Chih-Cheng Hsieh,

Clinical Outcome After Pulmonary Resection for Lung Cancer Patients on Hemodialysis Toshiro Obuchi, MD, Wakako Hamanaka, MD, Yasuhiro Yoshida, MD, Jun.

Lobectomy for Lung Cancer at Veterans Administration Medical Center Versus Academic Medical Center Travis Geraci, MD, Vanessa Baratta, MD, John Young,

Survival and Outcomes of Pulmonary Resection for Non-Small Cell Lung Cancer in the Elderly: A Nested Case-Control Study Robert J. Cerfolio, MD, Ayesha.

Mark I. Block, MD The Annals of Thoracic Surgery

Lobectomy Versus Limited Resection in T1N0 Lung Cancer

Domenico Galetta, MD, PhD, Lorenzo Spaggiari, MD, PhD

Esophagectomy for T1 Esophageal Cancer: Outcomes in 100 Patients and Implications for Endoscopic Therapy Arjun Pennathur, MD, Andrew Farkas, BA, Alyssa.

Early Surgical Results After Pneumonectomy for Non-Small Cell Lung Cancer are not Affected by Preoperative Radiotherapy and Chemotherapy Tomas Gudbjartsson,

Long-Term Results of Sleeve Lobectomy in the Management of Non–Small Cell Lung Carcinoma and Low-Grade Neoplasms Robert E. Merritt, MD, Douglas J. Mathisen,

Visceral Pleural Invasion Is Not a Significant Prognostic Factor in Patients With a Part- Solid Lung Cancer Aritoshi Hattori, MD, Kenji Suzuki, MD, Takeshi.

Video-Assisted Thoracoscopic Surgery Is a Safe and Effective Alternative to Thoracotomy for Anatomical Segmentectomy in Patients With Clinical Stage I.

Presentation transcript:

Alcohol Abuse Predicts Progression of Disease and Death in Patients with Lung Cancer Douglas E. Paull, MD, Glenda M. Updyke, PA-C, Michael A. Baumann, MD, Hong W. Chin, MD, Alex G. Little, MD, Samuel A. Adebonojo, MD The Annals of Thoracic Surgery Volume 80, Issue 3, Pages 1033-1039 (September 2005) DOI: 10.1016/j.athoracsur.2005.03.071 Copyright © 2005 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 (A) Overall survival of 36 alcohol-abusing patients (Etoh; broken line) and 78 nonabusing patients (Non-etoh; solid line) with nonsmall-cell lung cancer (NSCLC). aMedian survival in months (95% confidence intervals). bGehans-Wilcoxon log-rank test. Error bars ± SEM. (B) Progression-free survival of 36 alcohol-abusing patients (Etoh; broken line) and 78 nonabusing patients (Non-etoh; solid line) with NSCLC. aMedian survival in months (95% confidence intervals). bGehans-Wilcoxon log-rank test. cProgression = 20% increase in size of measurable disease or any new lesions. Error bars ± SEM. The Annals of Thoracic Surgery 2005 80, 1033-1039DOI: (10.1016/j.athoracsur.2005.03.071) Copyright © 2005 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 (A) Overall survival of 18 alcohol-abusing patients (Etoh; broken line) and 33 nonabusing patients (Non-etoh; solid line) with stage III nonsmall-cell lung cancer (NSCLC). aMedian survival in months (95% confidence intervals). bGehans-Wilcoxon log-rank test. Error bars ± SEM. (B) Progression-free survival of 18 alcohol-abusing patients (Etoh; broken line) and 33 nonabusing patients (Non-etoh; solid line) with stage III NSCLC. aMedian survival in months (95% confidence intervals). bGehans-Wilcoxon log-rank test. cProgression = 20% increase in size of measurable disease or any new lesions. Error bars ± SEM. The Annals of Thoracic Surgery 2005 80, 1033-1039DOI: (10.1016/j.athoracsur.2005.03.071) Copyright © 2005 The Society of Thoracic Surgeons Terms and Conditions